Enrollment completed in Phase III Copaxone MS trial
Enrollment completed in Phase III Copaxone MS trial
Teva Pharmaceutical Industries Ltd. today announced completion of patient enrollment for the GALA (Glatiramer Acetate Low-frequency Administration) trial. This international Phase III trial in patients with relapsing-remitting multiple sclerosis (RRMS), is designed to examine the efficacy, safe... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1767
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2046 Views
-
Last post by NHE
-
- 0 Replies
- 11067 Views
-
Last post by NHE
-
- 0 Replies
- 1108 Views
-
Last post by frodo
-
- 0 Replies
- 1472 Views
-
Last post by NHE
-
- 1 Replies
- 2731 Views
-
Last post by Tif
-
- 2 Replies
- 3911 Views
-
Last post by DIM
-
- 0 Replies
- 2216 Views
-
Last post by NHE
-
- 0 Replies
- 11239 Views
-
Last post by NHE
-
- 0 Replies
- 2185 Views
-
Last post by NHE